Kevin Blake

1.5k total citations
34 papers, 1.1k citations indexed

About

Kevin Blake is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Toxicology. According to data from OpenAlex, Kevin Blake has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 9 papers in Economics and Econometrics and 8 papers in Toxicology. Recurrent topics in Kevin Blake's work include Birth, Development, and Health (9 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Kevin Blake is often cited by papers focused on Birth, Development, and Health (9 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Kevin Blake collaborates with scholars based in Netherlands, Australia and Sweden. Kevin Blake's co-authors include John P. Newnham, Lawrence J. Beilin, Louis I. Landau, Fiona Stanley, Garth Kendall, Lyle C. Gurrin, Sharon Evans, Wendy H. Oddy, Lou I. Landau and Peter Arlett and has published in prestigious journals such as Nature Reviews Drug Discovery, Hypertension and The Journal of Pediatrics.

In The Last Decade

Kevin Blake

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Blake Netherlands 17 507 341 174 154 119 34 1.1k
Christian Hampp United States 19 133 0.3× 194 0.6× 72 0.4× 69 0.4× 42 0.4× 52 1.1k
Daniel B. Hawcutt United Kingdom 19 321 0.6× 74 0.2× 35 0.2× 64 0.4× 78 0.7× 111 1.3k
W. G. McBride Australia 19 397 0.8× 261 0.8× 104 0.6× 56 0.4× 71 0.6× 48 1.6k
Rita Ouellet‐Hellstrom United States 14 96 0.2× 145 0.4× 31 0.2× 101 0.7× 159 1.3× 23 1.6k
Euni Lee South Korea 21 122 0.2× 170 0.5× 33 0.2× 123 0.8× 53 0.4× 82 1.2k
Linda Härmark Netherlands 23 325 0.6× 156 0.5× 23 0.1× 297 1.9× 812 6.8× 59 1.4k
Juhaeri Juhaeri United States 24 128 0.3× 476 1.4× 15 0.1× 349 2.3× 76 0.6× 80 1.7k
Deborah Layton United Kingdom 24 155 0.3× 93 0.3× 13 0.1× 132 0.9× 220 1.8× 64 1.1k
June Raine Netherlands 19 172 0.3× 102 0.3× 13 0.1× 257 1.7× 266 2.2× 32 985
Ana Filipa Macedo Portugal 14 150 0.3× 134 0.4× 12 0.1× 530 3.4× 167 1.4× 20 2.1k

Countries citing papers authored by Kevin Blake

Since Specialization
Citations

This map shows the geographic impact of Kevin Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Blake more than expected).

Fields of papers citing papers by Kevin Blake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Blake. The network helps show where Kevin Blake may publish in the future.

Co-authorship network of co-authors of Kevin Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Blake. A scholar is included among the top collaborators of Kevin Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Blake. Kevin Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colin, Pieter, et al.. (2025). Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMA. Clinical Pharmacology & Therapeutics. 117(3). 808–817. 4 indexed citations
2.
Paixão, Paulo, Alfredo García‐Arieta, Nuno Silva, et al.. (2024). A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union. Pharmaceutics. 16(5). 598–598. 3 indexed citations
3.
Manolis, Efthymios, Alfredo García‐Arieta, Anders Lindahl, et al.. (2023). Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective. CPT Pharmacometrics & Systems Pharmacology. 12(5). 556–559. 12 indexed citations
4.
Hedenmalm, Karin, Kevin Blake, Katherine Donegan, et al.. (2019). A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiology and Drug Safety. 28(8). 1086–1096. 14 indexed citations
5.
Thomson, Andrew, Efthymios Manolis, Kevin Blake, et al.. (2019). Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics. British Journal of Clinical Pharmacology. 85(4). 659–668. 33 indexed citations
6.
Ponzano, Stefano, et al.. (2017). Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective. Clinical Pharmacology & Therapeutics. 103(4). 564–566. 3 indexed citations
7.
Blake, Kevin, et al.. (2015). Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports. Pediatric Drugs. 18(1). 55–63. 16 indexed citations
8.
9.
Arlett, Peter, et al.. (2014). Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee. Nature Reviews Drug Discovery. 13(5). 395–397. 36 indexed citations
10.
Keller‐Stanislawski, Brigitte, et al.. (2012). Drug-Induced PML: A Global Agenda for a Global Challenge. Clinical Pharmacology & Therapeutics. 91(4). 747–750. 14 indexed citations
11.
12.
Gopalakrishna, Deepak, et al.. (2011). Developments in Weather Responsive Traffic Management Strategies. 9 indexed citations
13.
Huang, Rae‐Chi, V. Burke, John P. Newnham, et al.. (2006). Perinatal and childhood origins of cardiovascular disease. International Journal of Obesity. 31(2). 236–244. 103 indexed citations
14.
Burke, Valerie, Lawrence J. Beilin, Karen Simmer, et al.. (2005). Breastfeeding and Overweight: Longitudinal Analysis in an Australian Birth Cohort. The Journal of Pediatrics. 147(1). 56–61. 76 indexed citations
15.
Burke, V., Lawrence J. Beilin, Karen Simmer, et al.. (2004). Predictors of body mass index and associations with cardiovascular risk factors in Australian children: a prospective cohort study. International Journal of Obesity. 29(1). 15–23. 133 indexed citations
16.
Burke, Valerie, Lawrence J. Beilin, Kevin Blake, et al.. (2004). Indicators of Fetal Growth Do Not Independently Predict Blood Pressure in 8-Year-Old Australians. Hypertension. 43(2). 208–213. 19 indexed citations
17.
Blake, Kevin, et al.. (2002). Prenatal ultrasound biometry related to subsequent blood pressure in childhood. Journal of Epidemiology & Community Health. 56(9). 713–718. 26 indexed citations
18.
Gurrin, Lyle C., Kevin Blake, Sharon Evans, & John P. Newnham. (2001). Statistical measures of foetal growth using linear mixed models applied to the foetal origins hypothesis. Statistics in Medicine. 20(22). 3391–3409. 25 indexed citations
19.
Blake, Kevin, Lyle C. Gurrin, Sharon Evans, et al.. (2000). Adjustment for current weight and the relationship between birth weight and blood pressure in childhood. Journal of Hypertension. 18(8). 1007–1012. 20 indexed citations
20.
Blake, Kevin, Lyle C. Gurrin, Sharon Evans, et al.. (2000). Maternal cigarette smoking during pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Human Development. 57(2). 137–147. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Hampp Breakdown of academic impact, for papers by Daniel B. Hawcutt Breakdown of academic impact, for papers by W. G. McBride Breakdown of academic impact, for papers by Rita Ouellet‐Hellstrom Breakdown of academic impact, for papers by Euni Lee Breakdown of academic impact, for papers by Linda Härmark Breakdown of academic impact, for papers by Juhaeri Juhaeri Breakdown of academic impact, for papers by Deborah Layton Breakdown of academic impact, for papers by June Raine Breakdown of academic impact, for papers by Ana Filipa Macedo
Rankless by CCL
2026